Polar Capital Holdings PLC Agios Pharmaceuticals, Inc. Put Options Transaction History
Polar Capital Holdings PLC
- $14.9 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AGIO
# of Institutions
235Shares Held
59.9MCall Options Held
323KPut Options Held
367K-
Farallon Capital Management LLC San Francisco, CA5.7MShares$214 Million0.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$210 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$182 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$132 Million2.39% of portfolio
-
State Street Corp Boston, MA2.45MShares$92 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.06B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...